161 related articles for article (PubMed ID: 36672877)
21. Identification of an EMT-related Gene Signature Predicting Recurrence in Stage II/III Colorectal Cancer: A Retrospective Study in 1780 Patients.
Ren H; Bösch F; Pretzsch E; Jacob S; Westphalen CB; Walter Holch J; Werner J; Angele MK
Ann Surg; 2022 Nov; 276(5):897-904. PubMed ID: 35880752
[TBL] [Abstract][Full Text] [Related]
22. Identification and Clinical Validation of a Novel 4 Gene-Signature with Prognostic Utility in Colorectal Cancer.
Ahluwalia P; Mondal AK; Bloomer C; Fulzele S; Jones K; Ananth S; Gahlay GK; Heneidi S; Rojiani AM; Kota V; Kolhe R
Int J Mol Sci; 2019 Aug; 20(15):. PubMed ID: 31387239
[TBL] [Abstract][Full Text] [Related]
23. A molecular signature for the prediction of recurrence in colorectal cancer.
Wang L; Shen X; Wang Z; Xiao X; Wei P; Wang Q; Ren F; Wang Y; Liu Z; Sheng W; Huang W; Zhou X; Du X
Mol Cancer; 2015 Feb; 14(1):22. PubMed ID: 25645394
[TBL] [Abstract][Full Text] [Related]
24. Gene pair based prognostic signature for colorectal colon cancer.
Shu P; Wu J; Tong Y; Xu C; Zhang X
Medicine (Baltimore); 2018 Oct; 97(42):e12788. PubMed ID: 30334969
[TBL] [Abstract][Full Text] [Related]
25. Identification of an exosomal long non-coding RNAs panel for predicting recurrence risk in patients with colorectal cancer.
Zhang Y; Liu H; Liu X; Guo Y; Wang Y; Dai Y; Zhuo J; Wu B; Wang H; Zhang X
Aging (Albany NY); 2020 Apr; 12(7):6067-6088. PubMed ID: 32246818
[TBL] [Abstract][Full Text] [Related]
26. Characterization of sialylation-related long noncoding RNAs to develop a novel signature for predicting prognosis, immune landscape, and chemotherapy response in colorectal cancer.
Zhou M; Lv S; Hou Y; Zhang R; Wang W; Yan Z; Li T; Gan W; Zeng Z; Zhang F; Yang M
Front Immunol; 2022; 13():994874. PubMed ID: 36330513
[TBL] [Abstract][Full Text] [Related]
27. Absence of MMP2 expression correlates with poor clinical outcomes in rectal cancer, and is distinct from MMP1-related outcomes in colon cancer.
Wong JC; Chan SK; Schaeffer DF; Sagaert X; Lim HJ; Kennecke H; Owen DA; Suh KW; Kim YB; Tai IT
Clin Cancer Res; 2011 Jun; 17(12):4167-76. PubMed ID: 21531813
[TBL] [Abstract][Full Text] [Related]
28. Comprehensive Analysis of Gene Expression Profiles Identifies a
Chen Z; Chen M; Xue Z; Zhu X
Cancer Biother Radiopharm; 2021 Oct; 36(8):693-704. PubMed ID: 34520234
[No Abstract] [Full Text] [Related]
29. Identification of a 5-Gene-Based Scoring System by WGCNA and LASSO to Predict Prognosis for Rectal Cancer Patients.
Huang H; Xu S; Chen A; Li F; Wu J; Tu X; Hu K
Anal Cell Pathol (Amst); 2021; 2021():6697407. PubMed ID: 33833937
[TBL] [Abstract][Full Text] [Related]
30. Improving the overall survival prognosis prediction accuracy: A 9-gene signature in CRC patients.
Zheng W; Lu Y; Feng X; Yang C; Qiu L; Deng H; Xue Q; Sun K
Cancer Med; 2021 Sep; 10(17):5998-6009. PubMed ID: 34346563
[TBL] [Abstract][Full Text] [Related]
31. Integration of genetic signature and TNM staging system for predicting the relapse of locally advanced colorectal cancer.
Peng J; Wang Z; Chen W; Ding Y; Wang H; Huang H; Huang W; Cai S
Int J Colorectal Dis; 2010 Nov; 25(11):1277-85. PubMed ID: 20706727
[TBL] [Abstract][Full Text] [Related]
32. Novel Multiple miRNA-Based Signatures for Predicting Overall Survival and Recurrence-Free Survival of Colorectal Cancer Patients.
Qian J; Zeng L; Jiang X; Zhang Z; Luo X
Med Sci Monit; 2019 Sep; 25():7258-7271. PubMed ID: 31560680
[TBL] [Abstract][Full Text] [Related]
33. Clinical significance of SNORA42 as an oncogene and a prognostic biomarker in colorectal cancer.
Okugawa Y; Toiyama Y; Toden S; Mitoma H; Nagasaka T; Tanaka K; Inoue Y; Kusunoki M; Boland CR; Goel A
Gut; 2017 Jan; 66(1):107-117. PubMed ID: 26475630
[TBL] [Abstract][Full Text] [Related]
34. Prognostic and predictive value of a lncRNA signature in patients with stage II colon cancer.
Qu A; Wang Q; Chang Q; Liu J; Yang Y; Zhang X; Zhang Y; Zhang X; Wang H; Zhang Y
Sci Rep; 2023 Jan; 13(1):1350. PubMed ID: 36693876
[TBL] [Abstract][Full Text] [Related]
35. A Liquid Biopsy Assay for Noninvasive Identification of Lymph Node Metastases in T1 Colorectal Cancer.
Wada Y; Shimada M; Murano T; Takamaru H; Morine Y; Ikemoto T; Saito Y; Balaguer F; Bujanda L; Pellise M; Kato K; Saito Y; Ikematsu H; Goel A
Gastroenterology; 2021 Jul; 161(1):151-162.e1. PubMed ID: 33819484
[TBL] [Abstract][Full Text] [Related]
36. Eukaryotic elongation factor-2 kinase expression is an independent prognostic factor in colorectal cancer.
Ng TH; Sham KWY; Xie CM; Ng SSM; To KF; Tong JHM; Liu WYZ; Zhang L; Chan MTV; Wu WKK; Cheng CHK
BMC Cancer; 2019 Jul; 19(1):649. PubMed ID: 31266475
[TBL] [Abstract][Full Text] [Related]
37. [Predictive value of combination detection of tissue Pgp1 expression and preoperative serum CEA level for colorectal cancer].
Wu F; Chen L; Wu W; Jiang B; Su X
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Apr; 20(4):443-449. PubMed ID: 28440527
[TBL] [Abstract][Full Text] [Related]
38. Identification and validation of an immune prognostic signature in colorectal cancer.
Li M; Wang H; Li W; Peng Y; Xu F; Shang J; Dong S; Bu L; Wang H; Wei W; Hu Q; Liu L; Zhao Q
Int Immunopharmacol; 2020 Nov; 88():106868. PubMed ID: 32771948
[TBL] [Abstract][Full Text] [Related]
39. Long non-coding RNA profile study identifies a metabolism-related signature for colorectal cancer.
Lu Y; Wang W; Liu Z; Ma J; Zhou X; Fu W
Mol Med; 2021 Aug; 27(1):83. PubMed ID: 34344319
[TBL] [Abstract][Full Text] [Related]
40. A DNA methylation signature for the prediction of tumour recurrence in stage II colorectal cancer.
Li M; Zhu C; Xue Y; Miao C; He R; Li W; Zhang B; Yu W; Huang X; Lv M; Xu Y; Huang Q
Br J Cancer; 2023 May; 128(9):1681-1689. PubMed ID: 36828869
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
